22.08.2022 15:38:00
|
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates HNGR, SBTX, IEA, ZY
NEW YORK, Aug. 22, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Hanger, Inc. (NYSE: HNGR)'s sale to Patient Square Capital for $18.75 in cash per share. If you are a Hanger shareholder, click here to learn more about your rights and options.
Silverback Therapeutics, Inc. (NASDAQ: SBTX)'s merger with ARS Pharmaceuticals, Inc. Under the terms of the merger agreement, assuming that Silverback's net cash at closing is $240 million, Silverback equity holders are expected to own approximately 37% of the combined company. If you are a Silverback shareholder, click here to learn more about your rights and options.
Infrastructure & Energy Alternatives, Inc. (NASDAQ: IEA)'s sale to MasTec for $10.50 per share in cash and 0.0483 of a MasTec share for each IEA share. If you are an IEA shareholder, click here to learn more about your rights and options.
Zymergen Inc. (NASDAQ: ZY)'s sale to Ginkgo Bioworks for 0.9179 Ginkgo shares for each Zymergen share. If you are a Zymergen shareholder, click here to learn more about your rights and options.
Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com
View original content:https://www.prnewswire.com/news-releases/shareholder-investigation-notice-halper-sadeh-llp-investigates-hngr-sbtx-iea-zy-301609906.html
SOURCE Halper Sadeh LLP
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Silverback Therapeutics Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |